Back

Comparative efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: a Bayesian network meta-analysis of randomized controlled trials

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Striving for effective heart failure therapies Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Ms Iffat Zahan

Harefield Hospital, Harefield (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Survival benefits of SGLT2 inhibitors in very elderly patients with heart failure with preserved ejection fraction
Doctor Y. Ge (Beijing, CN)
Abstract Slides
Presentation thumbnail
Mendelian randomization unravels bidirectional effects of NAFLD and heart failure across subtypes
Mr S. Huang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Classification and regression tree analysis for identification of long-term risk in patients with heart failure with preserved ejection fraction. final results of the Argentine ARFEY-Preser Registry
Doctor E. Perna (Corrientes, AR)
Abstract Slides
Presentation thumbnail
Association between resting heart rate and clinical outcomes in heart failure with preserved ejection fraction: age stratified insights from the KUNIUMI Registry
Mr T. Matsuura (Kobe, JP)
Abstract Slides

Access the full session

Session thumbnail
Striving for effective heart failure therapies

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitors in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis
7 April 2022
thumbnail
Congress Presentation
Comparative effectiveness of novel anti-hyperlipidemic drugs in adults with hyperlipidemia: a systematic review and bayesian network meta-analysis
4 April 2025
thumbnail
Congress Presentation
Comparative effectiveness of GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors on cardiovascular outcomes: A comprehensive Bayesian network meta-analysis with intervention ranking
31 August 2025
thumbnail
Congress Presentation
Using bayesian method and network meta-analysis to augment the trial interpretation of RAAS inhibitor effects in patients
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources